Bohen Sean
SEC CIK 1831218 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| OLMA | Olema Pharmaceuticals, Inc. | Pres, CEO, Dir | 237.7K | — | $2.11M | 15 | 2021-09-01 | 2025-12-26 |
Most active insiders at OLMA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | CLARK IAN T | Dir | — | $7.87M |
| 2 | Zojwalla Naseem | Chief Medical Off | — | $7.53M |
| 3 | Myles David C. | CH. DISCOV, NON-CLIN DEV OFF | — | $4.66M |
| 4 | Kovacs Shane William Charles | CH. OPERATING, FINANCIAL OFF | — | $2.98M |
| 5 | Mitchell Shawnte | CLO | — | $951.5K |
| 6 | Harmon Cyrus | Dir | — | $743.8K |
| 7 | Austin Sasha Lu | VP of Fin, Ctrl | — | — |
| 8 | Bohen Sean | Pres, CEO, Dir | — | — |
| 9 | RAPPAPORT ANDREW | Dir | — | — |
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-30 | 2025-12-26 | OLMA | Olema Pharmaceuticals, Inc. | Bohen Sean | Pres, CEO, Dir | G - Gift | $0.00 | -8,500 | 237.7K | -3% | $0 | |
| 2024-12-11 | 2024-12-09 | OLMA | Olema Pharmaceuticals, Inc. | Bohen Sean | Pres AND CEO, Dir | A - Grant | $0.00 | +204.8K | 351.2K | +140% | $0 | |
| M | 2024-12-11 | 2024-12-10+ | OLMA | Olema Pharmaceuticals, Inc. | Bohen Sean | Pres AND CEO, Dir | S - Sale | $9.01 | -109.5K | 298.8K | -27% | -$986.4K |
| M | 2023-11-22 | 2023-11-21+ | OLMA | Olema Pharmaceuticals, Inc. | Bohen Sean | Pres AND CEO, Dir | S - Sale | $14.40 | -57.2K | 172.9K | -25% | -$824.1K |
| 2023-11-22 | 2023-11-20 | OLMA | Olema Pharmaceuticals, Inc. | Bohen Sean | Pres AND CEO, Dir | A - Grant | $0.00 | +110.2K | 202.2K | +120% | $0 | |
| A | 2022-09-23 | 2022-09-21 | OLMA | Olema Pharmaceuticals, Inc. | Bohen Sean | Pres AND CEO, Dir | P - Purchase | — | +20.0K | 74.3K | +37% | — |
| 2022-09-22 | 2022-09-21 | OLMA | Olema Pharmaceuticals, Inc. | Bohen Sean | Pres AND CEO, Dir | A - Grant | — | +20.0K | 74.3K | +37% | — | |
| DM | 2021-10-15 | 2021-10-14 | OLMA | Olema Pharmaceuticals, Inc. | Bohen Sean | Pres AND CEO, Dir | S - Sale+OE | $30.47 | -5,000 | 52.5K | -9% | -$152.4K |
| D | 2021-10-15 | 2021-10-14 | OLMA | Olema Pharmaceuticals, Inc. | Bohen Sean | Pres AND CEO, Dir | M - OptEx | $4.82 | +5,000 | 57.5K | +10% | +$24.1K |
| D | 2021-09-29 | 2021-09-27 | OLMA | Olema Pharmaceuticals, Inc. | Bohen Sean | Pres AND CEO, Dir | S - Sale+OE | $30.07 | -1,085 | 52.5K | -2% | -$32.6K |
| D | 2021-09-29 | 2021-09-27 | OLMA | Olema Pharmaceuticals, Inc. | Bohen Sean | Pres AND CEO, Dir | M - OptEx | $4.82 | +1,085 | 53.6K | +2% | +$5,230 |
| DM | 2021-09-09 | 2021-09-07+ | OLMA | Olema Pharmaceuticals, Inc. | Bohen Sean | Pres AND CEO, Dir | S - Sale+OE | $30.01 | -3,044 | 52.5K | -5% | -$91.4K |
| DM | 2021-09-09 | 2021-09-07+ | OLMA | Olema Pharmaceuticals, Inc. | Bohen Sean | Pres AND CEO, Dir | M - OptEx | $4.82 | +3,044 | 56.9K | +6% | +$14.7K |
| D | 2021-09-03 | 2021-09-01 | OLMA | Olema Pharmaceuticals, Inc. | Bohen Sean | Pres AND CEO, Dir | M - OptEx | $4.82 | +871 | 55.1K | +2% | +$4,198 |
| D | 2021-09-03 | 2021-09-01 | OLMA | Olema Pharmaceuticals, Inc. | Bohen Sean | Pres AND CEO, Dir | S - Sale+OE | $30.05 | -871 | 54.3K | -2% | -$26.2K |
Purchase Sale Sale after option exercise All abbreviations